Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.
about
Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab.Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.
P2860
Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cell Killing Mechanisms and Im ...... Disseminated i.p. Tumor Model.
@ast
Cell Killing Mechanisms and Im ...... Disseminated i.p. Tumor Model.
@en
type
label
Cell Killing Mechanisms and Im ...... Disseminated i.p. Tumor Model.
@ast
Cell Killing Mechanisms and Im ...... Disseminated i.p. Tumor Model.
@en
prefLabel
Cell Killing Mechanisms and Im ...... Disseminated i.p. Tumor Model.
@ast
Cell Killing Mechanisms and Im ...... Disseminated i.p. Tumor Model.
@en
P2093
P2860
P1433
P1476
Cell Killing Mechanisms and Im ...... Disseminated i.p. Tumor Model.
@en
P2093
Diane E Milenic
Kwamena E Baidoo
Kwon Joong Yong
Martin W Brechbiel
P2860
P304
P356
10.1371/JOURNAL.PONE.0159904
P407
P577
2016-07-28T00:00:00Z